This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Biotie Theraples Corp., Glykos Finland Oy. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: The Innovations of Karl-Anders Karlsson
Introduction
Karl-Anders Karlsson is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of oligosaccharide sequences for cancer diagnostics and treatment. With a total of 2 patents, his work has the potential to impact medical science profoundly.
Latest Patents
Karlsson's latest patents include "Tumor specific oligosaccharide sequences and use thereof" and "Influenza virus binding, sialylated oligosaccharide substance and use thereof." The first patent describes oligosaccharide sequences specifically expressed by human tumors. This invention relates to a method for determining an oligosaccharide sequence that includes a tumor-specific terminal N-acetylglucosamine residue in a biological sample. The presence of this sequence indicates the presence of cancer. Additionally, it provides antigenic substances and diagnostic agents, pharmaceutical compositions, and cancer vaccines that incorporate these oligosaccharide sequences. The second patent focuses on a human influenza virus binding substance containing at least one oligosaccharide chain, which is crucial for binding the virus effectively.
Career Highlights
Throughout his career, Karlsson has worked with several companies, including Glykos Finland Oy and Biotie Therapies Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biochemistry.
Collaborations
Karlsson has collaborated with notable professionals in his field, including Jari Natunen and Susann Teneberg. These collaborations have likely contributed to the advancement of his research and inventions.
Conclusion
Karl-Anders Karlsson's contributions to the field of biochemistry through his innovative patents demonstrate his commitment to advancing medical science. His work in developing oligosaccharide sequences for cancer diagnostics and treatment showcases the potential for significant advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile